Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people,The Lancet Diabetes & Endocrinology

当前位置： X-MOL 学术 › Lancet Diabetes Endocrinol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2024-07-23 , DOI: 10.1016/s2213-8587(24)00159-1
Kurt Taylor ₁ , Sophie Eastwood ₂ , Venexia Walker ₃ , Genevieve Cezard ₄ , Rochelle Knight ₅ , Marwa Al Arab ₁ , Yinghui Wei ₆ , Elsie M F Horne ₇ , Lucy Teece ₈ , Harriet Forbes ₉ , Alex Walker ₁₀ , Louis Fisher ₁₀ , Jon Massey ₁₀ , Lisa E M Hopcroft ₁₀ , Tom Palmer ₁₁ , Jose Cuitun Coronado ₁ , Samantha Ip ₁₂ , Simon Davy ₁₀ , Iain Dillingham ₁₀ , Caroline Morton ₁₀ , Felix Greaves ₁₃ , John Macleod ₁₄ , Ben Goldacre ₁₀ , Angela Wood ₁₅ , Nishi Chaturvedi ₂ , Jonathan A C Sterne ₁₆ , Rachel Denholm ₁₆ , , ,

Affiliation

Population Health Sciences, University of Bristol, Bristol, UK.
MRC Unit for Lifelong Health and Ageing, University College London, London, UK.
Population Health Sciences, University of Bristol, Bristol, UK; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK; Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
Population Health Sciences, University of Bristol, Bristol, UK; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK; NIHR Bristol Biomedical Research Centre, Bristol, UK; The National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol and Weston, Bristol, UK.
Centre for Mathematical Sciences, School of Engineering, Computing and Mathematics, University of Plymouth, Plymouth, UK.
Population Health Sciences, University of Bristol, Bristol, UK; NIHR Bristol Biomedical Research Centre, Bristol, UK.
Department of Population Health Sciences, University of Leicester, Leicester, UK.
Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
The Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Population Health Sciences, University of Bristol, Bristol, UK; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
National Institute for Health and Care Excellence, Manchester, UK; Department of Primary Care and Public Health, Imperial College London, London, UK.
Population Health Sciences, University of Bristol, Bristol, UK; NIHR Bristol Biomedical Research Centre, Bristol, UK; The National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol and Weston, Bristol, UK.
British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK; British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK; National Institute for Health and Care Research Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, UK; Cambridge Centre of Artificial Intelligence in Medicine, University of Cambridge, Cambridge, UK; Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK.
Population Health Sciences, University of Bristol, Bristol, UK; NIHR Bristol Biomedical Research Centre, Bristol, UK; Health Data Research UK South-West, Bristol, UK.

Some studies have shown that the incidence of type 2 diabetes increases after a diagnosis of COVID-19, although the evidence is not conclusive. However, the effects of the COVID-19 vaccine on this association, or the effect on other diabetes subtypes, are not clear. We aimed to investigate the association between COVID-19 and incidence of type 2, type 1, gestational and non-specific diabetes, and the effect of COVID- 19 vaccination, up to 52 weeks after diagnosis.

中文翻译：

英格兰 SARS-CoV-2 感染后糖尿病的发病率和 COVID-19 疫苗接种的影响：一项对 1600 万人的回顾性队列研究

一些研究表明，诊断为 COVID-19 后，2 型糖尿病的发病率会增加，尽管证据尚无定论。然而，COVID-19 疫苗对这种关联的影响或对其他糖尿病亚型的影响尚不清楚。我们旨在调查 COVID-19 与 2 型、1 型、妊娠和非特异性糖尿病发病率之间的关联，以及诊断后 52 周内 COVID-19 疫苗接种的影响。

更新日期：2024-07-23

点击分享查看原文

点击收藏

公开下载

阅读更多本刊新发论文